Clinical Cancer Research: 3 (4)

Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival.

H Satoh, H Ishikawa, H Kamma, Y T Yamashita, H Takahashi, M Ohtsuka and S Hasegawa

Clin Cancer Res April 1 1997 3 (4) 495-499;
Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma.

D J Lee, W M Koch, G Yoo, M Lango, A Reed, J Califano, J A Brennan, W H Westra, M Zahurak and D Sidransky

Clin Cancer Res April 1 1997 3 (4) 501-505;
Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.

J H Li, P Li, H Klamut and F F Liu

Clin Cancer Res April 1 1997 3 (4) 507-514;
Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.

V Rusch, D Klimstra, E Venkatraman, P W Pisters, J Langenfeld and E Dmitrovsky

Clin Cancer Res April 1 1997 3 (4) 515-522;
Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.

K Watanabe, K Sato, W Biernat, O Tachibana, K von Ammon, N Ogata, Y Yonekawa, P Kleihues and H Ohgaki

Clin Cancer Res April 1 1997 3 (4) 523-530;
Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.

I Osman, H I Scher, Z F Zhang, I Pellicer, R Hamza, S Eissa, H Khaled and C Cordon-Cardo

Clin Cancer Res April 1 1997 3 (4) 531-536;
A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.

G K Schwartz, D Ward, L Saltz, E S Casper, T Spiess, E Mullen, J Woodworth, R Venuti, P Zervos, A M Storniolo and D P Kelsen

Clin Cancer Res April 1 1997 3 (4) 537-543;
Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi.

C C Chen, B Meadows, J Regis, G Kalafsky, T Fojo, J A Carrasquillo and S E Bates

Clin Cancer Res April 1 1997 3 (4) 545-552;
Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data.

M Chazal, S Cheradame, J L Formento, M Francoual, P Formento, M C Etienne, E François, H Richelme, M Mousseau, C Letoublon, D Pezet, H Cure, J F Seitz and G Milano

Clin Cancer Res April 1 1997 3 (4) 553-557;
Cathepsin D and dynamic magnetic resonance imaging gadolinium enhancement in malignant and benign breast lesions.

P C Stomper, J S Winston, S Herman, D L Klippenstein and L E Blumenson

Clin Cancer Res April 1 1997 3 (4) 559-563;
Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanoma.

K Margolin, M Atkins, J Sparano, J Sosman, G Weiss, M Lotze, J Doroshow, J Mier, K O'Boyle, R Fisher, E Campbell, J Rubin, D Federighi and S Bursten

Clin Cancer Res April 1 1997 3 (4) 565-572;
IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma.

B Seliger, S Hammers, A Höhne, R Zeidler, A Knuth, C D Gerharz and C Huber

Clin Cancer Res April 1 1997 3 (4) 573-578;
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro.

I Faraoni, M Turriziani, G Masci, L De Vecchis, J W Shay, E Bonmassar and G Graziani

Clin Cancer Res April 1 1997 3 (4) 579-585;
Patterns of DNA ploidy and S-phase fraction associated with breast cancer survival in blacks and whites.

Y H Shiao, V W Chen, H P Lehmann, X C Wu and P Correa

Clin Cancer Res April 1 1997 3 (4) 587-592;
Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.

A Makris, T J Powles, M Dowsett, C K Osborne, P A Trott, I N Fernando, S E Ashley, M G Ormerod, J C Titley, R K Gregory and D C Allred

Clin Cancer Res April 1 1997 3 (4) 593-600;
Lack of prognostic significance of histological grade in node-negative invasive breast carcinoma.

M Younes and R Laucirica

Clin Cancer Res April 1 1997 3 (4) 601-604;
Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.

H Singhal, D S Bautista, K S Tonkin, F P O'Malley, A B Tuck, A F Chambers and J F Harris

Clin Cancer Res April 1 1997 3 (4) 605-611;
Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume.

K Fujikawa, M Sasaki, Y Arai, H Yamabe, O Ogawa and O Yoshida

Clin Cancer Res April 1 1997 3 (4) 613-618;
Clinical implications of telomerase activity levels in acute leukemia.

J H Ohyashiki, K Ohyashiki, H Iwama, S Hayashi, K Toyama and J W Shay

Clin Cancer Res April 1 1997 3 (4) 619-625;
Telomerase activity in normal and neoplastic breast.

J l Tsao, Y Zhao, J Lukas, X Yang, A Shah, M Press and D Shibata

Clin Cancer Res April 1 1997 3 (4) 627-631;
In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.

Y Fujimiya, Y Suzuki, R Katakura, T Miyagi, T Yamaguchi, T Yoshimoto and T Ebina

Clin Cancer Res April 1 1997 3 (4) 633-643;

Main menu

User menu

Search

Table of Contents

Articles

Info for

About Clinical Cancer Research